Alternatively, the BWXT Tc-99m generator will be produced from natural molybdenum targets irradiated at a commercial power reactor, greatly reducing complex waste by-products. These targets are ...

BWXT cautions that this release contains forward-looking statements, including statements relating to the production, performance, timing, impact and value of Tc-99m and changes in demand ...

The company plans to introduce the technology by the end of 2019, subject to regulatory approvals. BWXT's prototype Tc-99m generator (Image: BWXT) Featuring a patent-pending neutron capture process, ...

Before that, BWXT Medical submitted an application of Tc-99m in September 2022. This is where risks came in. The management expected FDA approval last year, but it has been delayed for a year and ...

Ontario Power Generation, its subsidiary Laurentis Energy Partners, BWXT ITG Canada Inc and its affiliates yesterday said they are making "significant progress" towards the production of molybdenum-99 ...

Once approved for commercial production by regulatory bodies, BWXT Medical’s new proprietary manufacturing technology will be used to irradiate molybdenum targets at an Ontario Power Generation ...